CSF2 and autoimmune disease: Similarly, we have previously reported the prevention and/or suppression of several experimental autoimmune diseases, such as type 1 diabetes8, autoimmune thyroiditis9–11, and myasthenia gravis12–14, upon treatment with granulocyte macrophage colony-stimulating factor (GM-CSF), another hematopoietic cytokine strongly linked to myeloproliferation as well as DC development.